Authors: Cotter, G Kiowski, W Kaluski, E Kobrin, I Milovanov, O Marmor, A Jafari, J Reisin, L Krakover, R Vered, Z Caspi, A

Citation: G. Cotter et al., Tezosentan (an intravenous endothelin receptor A/B antagonist) reduces peripheral resistance and increases cardiac power therefore preventing a steepdecrease in blood pressure in patients with congestive heart failure, EUR J HE FA, 3(4), 2001, pp. 457-461

Authors: Schlesinger, Z Vered, Z Friedenson, A Reisin, L Jafari, J Flieb, T Sclarovsky, S Friedman, Y Ostfeld, B Solodky, A Abinader, E Rochfleish, S Palant, A Schneider, H Rosenfeld, T Khalid, S Wolfson, E Kishon, Y Narinsky, R Rotzak, R Davidov, A Levine, G Zahavi, I Vitrai, J Diker, D Pelled, B Pardu, J Galamidi, J Majadla, R Laniado, S Sherf, L Braun, S Eschar, Y Caspi, A Arditi, A Botwin, S Arkavi, L Ziv, M David, D Weisenberg, D Kohanovski, M Meisel, S Rougin, N Yahalom, M Glusman-Vazan, A Markiewitz, W Motlak, D Lessick, J Kagan, G Marmour, A Flich, M Solomon, R Tzivoni, D Zion, M Balkin, J Rabinowitz, B Barasch, E Brill, Z Aharon, L Asman, A Battler, A Gueron, M Cristal, N Liel, N Tsatskis, B Henkin, J

Citation: Z. Schlesinger et al., Secondary prevention by raising HDL cholesterol and reducing triglyceridesin patients with coronary artery disease - The bezafibrate infarction prevention (BIP) study, CIRCULATION, 102(1), 2000, pp. 21-27

Authors: Mishal, J Ben-Israel, N Levin, Y Sherf, S Jafari, J Embon, E Sherer, Y

Citation: J. Mishal et al., Brucellosis outbreak: Analysis of risk factors and serologic screening, INT J MOL M, 4(6), 1999, pp. 655-658

Authors: Yosefy, C Linov, L Viskoper, JR Hay, E Jafari, J Nasri, Y Peled, R Reisin, L

Citation: C. Yosefy et al., Prior antihypertensive treatment and admission blood pressure correlated with clinical outcome and early morning presentation in hypertensive ischaemic stroke patients, J HUM HYPER, 13(11), 1999, pp. 765-769